[Should conversion enzyme inhibitors be use in renal insufficiency?].
Several experimental studies have shown an interaction between renin-angiotensin-aldosterone system and erythropoiesis, while several clinical studies in essentially patients with chronic renal failure have reported that ACE-inhibitor interfere with erythropoiesis. The clinical consequences of this effect need to be determined before condemning ACE-inhibitor use in this patients.